Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RBM7 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DHODH - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HEATR1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RAP1GAP2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Profile neighbors
TNFRSF17 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PUS3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HERC4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LOC102723407 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LMO1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TRMO - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GZMB - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CAST - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MTHFR - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
COPS2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LINC00483 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
GPR42 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SUGP2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NTRK2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
IRF4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on